David Eyerman

Company: Apellis Pharmaceuticals

Job title: VP, Translational Neurology

Seminars:

Demonstrating Translatable Oligonucleotide Tolerability & PKPD Across In Vitro & NHP Models 1:00 pm

Accumulating tolerability data in vitro and in vivo to predict optimum sequence and formulation for larger species dosing Integrating efficient in vitro and in rodent models to better predict candidate tolerability and efficacy in higher species Improving in silico models to better predict human dose selectionRead more

day: Conference Day Two